Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended (No longer looking for participants). New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was revised.
    Difference
    0.8%
    Check dated 2026-06-12T16:23:41.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing v3.5.4. This reflects a routine site update that does not alter the study details or page content.
    Difference
    0.0%
    Check dated 2026-06-05T11:50:54.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    A new Sample Collection element was added to the study plan, and the record version was updated to v3.5.4, replacing the previous v3.5.3 revision.
    Difference
    0.2%
    Check dated 2026-05-15T02:30:22.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added, replacing the previous v3.5.2. This indicates an administrative update to the page.
    Difference
    0.0%
    Check dated 2026-04-30T16:51:09.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    New page revision 3.5.2 was added on 2026-04-13 and an older revision 3.5.0 was removed on 2026-04-07. These entries reflect metadata about the page version rather than substantive updates to the study details.
    Difference
    0.1%
    Check dated 2026-04-16T11:17:20.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Study record timeline updated: 2026-04-07 and 2026-04-08 were added, while 2026-04-01 and 2026-03-31 were removed. These are administrative updates and do not alter core trial content such as eligibility, interventions, or outcomes.
    Difference
    0.1%
    Check dated 2026-04-09T08:31:16.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.